Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$370,000 |
 |
ModernaMRNA |
$16,000 |
 |
Eli Lilly and CompanyLLY |
-$87,000 |
Are Members of Congress Buying or Selling AbbVie?
No members of Congress have reported trading AbbVie (ABBV) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the ABBV AI Score. For corporate insider activity, see ABBV insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading AbbVie?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Jefferson Shreve | Mixed $150,000 | 2 | Apr 17, 2025 |
| Ro Khanna | Bought $41,000 | 2 | May 1, 2026 |
| Julia Letlow | Mixed $32,000 | 4 | Dec 8, 2025 |
| Marjorie Taylor Greene | Bought $32,000 | 4 | Aug 4, 2025 |
| Josh Gottheimer | Bought $24,000 | 4 | May 5, 2026 |
| Lisa McClain | Bought $24,000 | 4 | Oct 31, 2025 |
ABBV Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Josh Gottheimer | May 5, 2026 | Sell | $1K – $15K |
| Ro Khanna | May 1, 2026 | Buy | $15K – $50K |
| Julie Johnson | Dec 18, 2025 | Sell | $1K – $15K |
| Julia Letlow | Dec 8, 2025 | Sell | $1K – $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K – $15K |
| Lisa McClain | Oct 31, 2025 | Sell | $1K – $15K |
| Lisa McClain | Oct 30, 2025 | Buy | $1K – $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K – $15K |
| Marjorie Taylor Greene | Aug 4, 2025 | Buy | $1K – $15K |
| Lisa McClain | Jul 22, 2025 | Buy | $1K – $15K |
| Ritchie Torres | Jul 11, 2025 | Sell | $1K – $15K |
| Lisa McClain | Jun 17, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | May 22, 2025 | Buy | $1K – $15K |
| Rob Bresnahan | May 15, 2025 | Buy | $1K – $15K |
| Marjorie Taylor Greene | May 5, 2025 | Buy | $1K – $15K |
| Julia Letlow | Apr 28, 2025 | Buy | $1K – $15K |
| Jefferson Shreve | Apr 17, 2025 | Sell | $50K – $100K |
| Jared Moskowitz | Apr 7, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Apr 3, 2025 | Buy | $1K – $15K |
| Dwight Evans | Apr 3, 2025 | Sell | $1K – $15K |
| Josh Gottheimer | Apr 1, 2025 | Buy | $1K – $15K |
| Marjorie Taylor Greene | Mar 17, 2025 | Buy | $1K – $15K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $1K – $15K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $50K – $100K |
| Julia Letlow | Jan 24, 2025 | Sell | $1K – $15K |
| Jared Moskowitz | Jan 15, 2025 | Buy | $1K – $15K |
| Virginia Foxx | Dec 6, 2024 | Buy | $1K – $15K |
| Marjorie Taylor Greene | Nov 20, 2024 | Buy | $1K – $15K |
| Marjorie Taylor Mrs Greene | Nov 20, 2024 | Buy | $1K – $15K |
| Julia Letlow | Oct 23, 2024 | Buy | $1K – $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K – $15K |
| Ritchie Torres | Sep 26, 2024 | Buy | $1K – $15K |
Frequently Asked Questions: AbbVie Congress Trading
No members of Congress have reported buying or selling ABBV stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Josh Gottheimer sold AbbVie (ABBV) stock most recently, on May 5, 2026.
The estimated net value of congressional trades in AbbVie over the past 2 years is positive, at $120,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
